NCT06617832View on ClinicalTrials.gov

Trial Designs for Evaluating Migraine Treatment

NARecruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

November 13, 2024

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2028

Conditions
Migraine with AuraMigraine Without AuraHeadache, Migraine
Interventions
DRUG

Active drug for acute migraine treatment

Standard dose of Sumatriptan 100 mg, which is used as an acute treatment for episodic migraine

DRUG

Placebo Oral Tablet

Inactive placebo pill (100 mg) looking like the active drug

Trial Locations (2)

8000

NOT_YET_RECRUITING

Dept. of Psychology and Behavioural Sciences, Aarhus C

8200

RECRUITING

Department of Clinical Medicine, Aarhus University Hospital, Aarhus N

All Listed Sponsors
lead

University of Aarhus

OTHER